Wave Life Sciences

Wave Life Sciences company information, Employees & Contact Information

We are a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Our toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing us with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Our diversified pipeline includes clinical programs in Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, and obesity, as well as several preclinical programs utilizing our broad RNA therapeutics toolkit. Driven by the calling to “Reimagine Possible”, we are leading the charge toward a world in which human potential is no longer hindered by the burden of disease.

Company Details

Employees
361
Founded
-
Address
733 Concord Avenue, Cambridge,massachusetts 02138,united States
Phone
617-949-2900
Email
in****@****sci.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Cambridge, Massachusetts
Looking for a particular Wave Life Sciences employee's phone or email?

Wave Life Sciences Questions

News

Wave Life Sciences Announces Virtual Research Day on - GlobeNewswire

Wave Life Sciences Announces Virtual Research Day on GlobeNewswire

RNA Medicine Pioneer Wave Life Sciences Sets Major Research Day, Conference Circuit Schedule - Stock Titan

RNA Medicine Pioneer Wave Life Sciences Sets Major Research Day, Conference Circuit Schedule Stock Titan

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Wave Life Sciences RNA Medicine Pioneer Announces Q2 2025 Earnings Date - Key Updates Expected - Stock Titan

Wave Life Sciences RNA Medicine Pioneer Announces Q2 2025 Earnings Date - Key Updates Expected Stock Titan

Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 - GlobeNewswire

Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 GlobeNewswire

Wave Life Sciences to Host Webcast for Q2 2025 Financial Results and Business Updates - Quiver Quantitative

Wave Life Sciences to Host Webcast for Q2 2025 Financial Results and Business Updates Quiver Quantitative

GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets - GSK

GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets GSK

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs - Yahoo Finance

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs Yahoo Finance

Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation - Yahoo Finance

Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation Yahoo Finance

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 - GlobeNewswire

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 GlobeNewswire

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer GlobeNewswire

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity - GlobeNewswire

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity GlobeNewswire

Wave Life Sciences Announces Submission of First Clinical - GlobeNewswire

Wave Life Sciences Announces Submission of First Clinical GlobeNewswire

Wave Life Sciences Announces Positive Update from Ongoing - GlobeNewswire

Wave Life Sciences Announces Positive Update from Ongoing GlobeNewswire

Wave Life Sciences Announces First-Ever Therapeutic RNA - GlobeNewswire

Wave Life Sciences Announces First-Ever Therapeutic RNA GlobeNewswire

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update GlobeNewswire

Wave Life Sciences Announces Positive Results from Phase - GlobeNewswire

Wave Life Sciences Announces Positive Results from Phase GlobeNewswire

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions - GlobeNewswire

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions GlobeNewswire

Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping - GlobeNewswire

Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping GlobeNewswire

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 - GlobeNewswire

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 GlobeNewswire

Breakthrough: First-Ever Restored AAT Production of 20.6µM Achieved in Wave's AATD Treatment Trial - Stock Titan

Breakthrough: First-Ever Restored AAT Production of 20.6µM Achieved in Wave's AATD Treatment Trial Stock Titan

Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewswire

Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants GlobeNewswire

Wave Life Sciences Announces Continued Momentum in GSK - GlobeNewswire

Wave Life Sciences Announces Continued Momentum in GSK GlobeNewswire

Wave Life Sciences and GSK Announce Collaboration to Drive - GlobeNewswire

Wave Life Sciences and GSK Announce Collaboration to Drive GlobeNewswire

Wave Life Sciences Announces Approval of First Clinical - GlobeNewswire

Wave Life Sciences Announces Approval of First Clinical GlobeNewswire

Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy - GlobeNewswire

Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy GlobeNewswire

DMD Treatment Gets Orphan Drug, Rare Pediatric Disease Designations - Medical Professionals Reference

DMD Treatment Gets Orphan Drug, Rare Pediatric Disease Designations Medical Professionals Reference

Wave Life Sciences and Takeda Form Global Strategic - GlobeNewswire

Wave Life Sciences and Takeda Form Global Strategic GlobeNewswire

Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer - GlobeNewswire

Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer GlobeNewswire

Top Wave Life Sciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant